-
1 Comment
From a valuation standpoint, the stock is 99.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 10.6.
Based on the above factors, Vivos Therapeutics, Inc gets an overall score of 1/5.
Exchange | NASDAQ |
---|---|
Sector | Healthcare |
Industry | Medical Devices |
CurrencyCode | USD |
ISIN | US92859E1082 |
Market Cap | 16M |
---|---|
PE Ratio | None |
Target Price | 5.85 |
Beta | 7.28 |
Dividend Yield | None |
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for VVOS using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025